High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction.
Takahashi T, Terazono H, Suetsugu T, Sugawara H, Arima J, Nitta M, Tanabe T, Okutsu K, Ikeda R, Mizuno K, Inoue H, Takeda Y.
Takahashi T, et al. Among authors: suetsugu t.
Cancers (Basel). 2021 Jul 8;13(14):3425. doi: 10.3390/cancers13143425.
Cancers (Basel). 2021.
PMID: 34298637
Free PMC article.